A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel in Adult Hypogonadal Males
Completed · Phase 3
Conditions studied: Adult Male Hypogonadism
In brief
This is a phase 3, open-label, non-randomized, clinical trial to evaluate the efficacy and safety of FE 999303 (Testosterone gel) in adult hypogonadal males.
Key facts
- Study ID
- NCT02149264
- Run by
- Ferring Pharmaceuticals
- People needed
- 160
- Starts
- 2014-07-01
- Expected to finish
- 2015-06-01
- Last updated by the study team
- 2017-10-26
Who can join
Age: 18 and older, up to 75. Sex: male. Healthy volunteers: not accepted.
You may qualify if…
- Males between 18-75 years of age
- Two fasting serum testosterone levels <300 ng/dL
You may not qualify if…
- Previous use of the study drug
- History of prostate or breast cancer
- Prostate-Specific Antigen (PSA) ≥3 ng/mL
- Subject is sexually active and not willing to use adequate contraception
Where it is running
- Investigational site — Anniston, Alabama, United States
- Investigational site — Huntsville, Alabama, United States
- Investigational site — Newport Beach, California, United States
- Investigational site — Denver, Colorado, United States
- Investigational site — New Haven, Connecticut, United States
- Investigational site — Aventura, Florida, United States
- Investigational site — Clearwater, Florida, United States
- Investigational site — Mishawaka, Indiana, United States
- Investigational site — Watertown, Massachusetts, United States
- Investigational site — Troy, Michigan, United States
- Investigational site — Edison, New Jersey, United States
- Investigational site — Lawrence, New Jersey, United States
- Investigational site — Garden City, New York, United States
- Investigational site — New York, New York, United States
- Investigational site — Poughkeepsie, New York, United States
- Investigational site — Purchase, New York, United States
- Investigational site — Bala-Cynwyd, Pennsylvania, United States
- Investigational site — Warwick, Rhode Island, United States
- Investigational site — Mt. Pleasant, South Carolina, United States
- Investigational site — Nashville, Tennessee, United States
- Investigational site — Webster, Texas, United States
- Investigational site — Norfolk, Virginia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.